Randomised Evaluation of Modified Valsalva Effectiveness in Re-Entrant Tachycardias (REVERT)

2.50
Hdl Handle:
http://hdl.handle.net/11287/583449
Title:
Randomised Evaluation of Modified Valsalva Effectiveness in Re-Entrant Tachycardias (REVERT)
Authors:
Appelboam, Andrew; Reuben, Adam; Mann, C; Ewings, P; Benger, P; Vickery, J; Ingram, W; Barton, A; Gagg, J
Abstract:
The Valsalva manoeuvre is an internationally recommended physical emergency treatment for supraventricular tachycardia (SVT), an abnormal fast heart rhythm. However in normal practice, the manoeuvre only works in 5–20% of cases and intravenous treatment with adenosine is required. This drug causes a pause in heart activity which patients often find very distressing. A simple posture modification to the Valsalva manoeuvre could improve its effectiveness and we carried out a randomised controlled trial to assess whether it could increase the rate of cardioversion and reduce use of adenosine.
Issue Date:
5-Nov-2015
URI:
http://hdl.handle.net/11287/583449
Type:
Meetings and Proceedings
Language:
en
Description:
Conference poster
Sponsors:
REVERT is funded by the National Institute for Health Research (NIHR) through its Research for Patient Benefit (RfPB) Programme: Grant Reference Number PB-PG-0211-24145. The study has been approved by the South West Exeter Research Ethics Committee, is registered with Current Controlled Trials (ISRCTN67937027) and has been adopted by the NIHR Clinical Research Network.
Appears in Collections:
2015 RD&E publications; Emergency Department

Full metadata record

DC FieldValue Language
dc.contributor.authorAppelboam, Andrewen
dc.contributor.authorReuben, Adamen
dc.contributor.authorMann, Cen
dc.contributor.authorEwings, Pen
dc.contributor.authorBenger, Pen
dc.contributor.authorVickery, Jen
dc.contributor.authorIngram, Wen
dc.contributor.authorBarton, Aen
dc.contributor.authorGagg, Jen
dc.date.accessioned2015-12-09T11:34:29Zen
dc.date.available2015-12-09T11:34:29Zen
dc.date.issued2015-11-05en
dc.identifier.urihttp://hdl.handle.net/11287/583449en
dc.descriptionConference posteren
dc.description.abstractThe Valsalva manoeuvre is an internationally recommended physical emergency treatment for supraventricular tachycardia (SVT), an abnormal fast heart rhythm. However in normal practice, the manoeuvre only works in 5–20% of cases and intravenous treatment with adenosine is required. This drug causes a pause in heart activity which patients often find very distressing. A simple posture modification to the Valsalva manoeuvre could improve its effectiveness and we carried out a randomised controlled trial to assess whether it could increase the rate of cardioversion and reduce use of adenosine.en
dc.description.sponsorshipREVERT is funded by the National Institute for Health Research (NIHR) through its Research for Patient Benefit (RfPB) Programme: Grant Reference Number PB-PG-0211-24145. The study has been approved by the South West Exeter Research Ethics Committee, is registered with Current Controlled Trials (ISRCTN67937027) and has been adopted by the NIHR Clinical Research Network.en
dc.language.isoenen
dc.titleRandomised Evaluation of Modified Valsalva Effectiveness in Re-Entrant Tachycardias (REVERT)en
dc.typeMeetings and Proceedingsen
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.